📊 Backtest📒 Journal Updated 14/07/2026
← 🔥 Turbo
📐 Simulate Position
FRESHReport written today · at $7.32

CRML

ค่าขนมSMALL CAP
Critical Metals Corp. · NASDAQ · Materials / Rare Earth & Critical Minerals Mining
$7.32
▼ 6.14%
MCap $1.1B
Down 6.14% today (self-fetched — not yet in live-prices.json cache, new pick this run). Down sharply from the 52-week high of $32.15 to near the 52-week low of $2.83 — an 11x range in one year shows how violently this name can move in either direction.
BusinessRare earth + lithium developer · 92.5% owner of Tanbreez (one of the largest known rare-earth resources globally, Greenland) + Wolfsberg Lithium Project (Austria, BMW offtake) · 10,000m Tanbreez drill campaign underway
Thesis

Critical Metals raised its ownership of the Tanbreez rare-earth project in Greenland — one of the largest known rare-earth resources globally — to 92.5%, and already has a 15-year offtake agreement with REalloys for 15% of Phase 1 production. A 10,000-meter diamond drilling campaign is underway (launched Jun 17, 2026), with assay results the near-term catalyst. Consensus analyst targets ($13.50-$20, avg $18.33) imply 146-169% upside from the crashed price — below the traditional 200% floor on a strict consensus basis, but the stock's own demonstrated 52-week range ($2.83-$32.15) shows a credible path to 200%+ if drilling results are strong, which is the basis for including it here. ⚠️ SURVIVAL: cash burn is real (pre-raise runway estimated at just 4 months on free-cash-flow terms) and the company has filed three separate shelf registrations in 2026 (Feb, Mar, May) — genuine, active dilution machinery, even after large recent capital raises.

📝 Primary Verdict · Core Holding
SPECULATIVEค่าขนม

ค่าขนม — genuine scale rare-earth resource (92.5% of Tanbreez) with a real offtake deal already signed, but active recurring dilution and pre-revenue status make this a real lottery-ticket setup. Size small and expect volatility.

88
score / 100 ⓘ
⚡ Catalyst
⛏️ Tanbreez 10,000m Drilling Campaign — Assay ResultsONGOING — RESULTS PENDING

Diamond drilling campaign launched Jun 17, 2026 at the wholly-controlled Tanbreez Heavy REE Project. Prior assay results in Feb 2026 were already the strongest to date from the Hill Deposit — further strong results would reinforce the resource-scale thesis ahead of a late-2026 production target.

H2 2026
📜 REalloys 15-Year Offtake Agreement ExecutionONGOING

Definitive 15-year agreement for 15% of Tanbreez Phase 1 rare-earth concentrate production, announced alongside the May 2026 shelf filing — a real commercial validation, not just a resource story.

Ongoing
🏭 Targeted Late-2026 Production StartLATE 2026

Company still has a complex build to deliver in a remote Greenland location before targeted late-2026 production — the ultimate proof point for the whole thesis.

Late 2026
🎯 Entry Point
Entry 1
$7.32
Current — well off the 52-week high, pre-assay-results setupNow (small)
Entry 2PREFERRED
$5.5–6.5
Further dip zone — better R/R ahead of drilling assay resultsIf dips
Entry 3
$4.00
Deep dip — near 52-week low territory, verify no dilutive-raise news firstDeep dip (verify financing news first)
✅ Take Profit
TP1
Base — assay results in-line, offtake/production narrative intact
$12.44
+70%
TP2
Bull — strong assay results, consensus target reached
$18.3
+150%
TP3 🌙
Moon — production narrative validated, stock revisits its own 52-week high
$32.15
+339%
🔴 Stop Loss
Tight Stop
Below Entry 2 zone — assay results disappointing or fresh dilutive raise
$5.5
-24.9%
Hard Stop
Near 52-week low breach — thesis-level breach
$3.5
-52.2%
Risk / Reward
From Entry 2 ($6 mid) tight stop vs TP2
3.5 : 1
⚠ ค่าขนม — real dilution machinery active. Size ≤3% of portfolio.
📅 Estimate Date
Tanbreez Drilling Assay Results
10,000m campaign underway — results are the near-term re-rate catalyst
H2 2026
Binary: strong / in-line / weak assays
Targeted Production Start
The ultimate proof point — a complex remote-location build still has to be delivered
Late 2026
Target: late 2026
📈 Possible Up % — Scenario Spread
Bear
-60%
$2.93
Base
+70%
$12.44
Bull
+150%
$18.3
Moon
+339%
$32.15
← downsideupside →
🏛️ Fed / Macro Risk — LOW

Assesses how Fed policy / interest rates / inflation affect this stock — LOW = minimal risk, HIGH = proceed with caution

Rate Outlook
Fed at 3.50-3.75%; CRML's thesis is resource/geopolitics-driven (China rare-earth supply concerns, Project Vault-style federal critical-minerals policy), largely decoupled from the rate cycle.
Inflation
Core PCE at 3.4% YoY doesn't materially change the rare-earth supply-security narrative driving this stock.
Sector Impact
MEDIUM-HIGH. As a genuinely small, pre-revenue, high-beta resource name with active dilution machinery, CRML is more exposed than most to a risk-off macro tape that raises the cost of its next capital raise.
Summary
Fed risk LOW-MEDIUM on the core thesis (geopolitics/resource-driven, not rate-driven), but the active, recurring shelf-filing pattern means a hawkish, risk-off macro week could make the company's ongoing capital needs more expensive or dilutive right when it needs flexibility most.
🎯 Analyst Targets

Wall Street price targets vs the current price — cross-check our TP levels

Consensus (avg)
Buy$18.33+150%
Texas Capital
Buy$20+173%
current price $7.32
🔍 Similar-Catalyst Comparable Check

Stocks that went through similar catalyst events — calibrate whether the +30%+ target is realistic

CRML✅ Good2026
+19.8%
in 1 day
15-Year Tanbreez Rare Earth Offtake Deal Announcement
Same-company precedent for a major commercial validation event — the closest available comp for how the market reacts to CRML executing on the Tanbreez thesis.
NB✅ Good2026
+12%
in 1 day
NioCorp Elk Creek Mine Portal Project Board Approval
Comparable US/critical-minerals-project milestone reaction — a more modest same-sector comp useful as a sanity check on the postWin range.
CRML❌ Bad2026
-77%
in 180 days
Stock decline from 52-week high ($32.15) to current levels
Same-company precedent for the scale of drawdown this stock has already demonstrated — directly relevant context for sizing the downside risk honestly.
⚡ Optional Layer · Tactical Overlay
🎯 Catalyst Spot Mode

Short-term play around the catalyst (Sep 2026 earnings) only — an optional overlay, not a verdict that ranks equal to the Core Holding.

⚠️

Use this stop-loss set (-25% / -35%) only when trading the earnings spot — not for the core holding (use the -24.9% / -52.2% set above). If you are holding long-term, follow the core set.

📈Pre-Catalyst Run-up Pattern
+15% to +20% same-day pop pattern on major validation newsreacts same-day to assay/offtake/financing news, not a sustained pre-event drift

CRML has shown it can move 15-20%+ same-day on major commercial/resource validation news — the offtake deal announcement and strong assay results have both triggered sharp pops this year.

🎲Historical Post-Catalyst Move
✅ Catalyst Winavg +17%
range: +15% to +20%· 2026
CRML's own 15-year Tanbreez offtake deal announcement drove a +19.8% same-day pop — the most directly relevant same-company precedent for how the market reacts to major positive validation, though strong assay results specifically could plausibly move it further given the stock's demonstrated volatility.
❌ Catalyst Missavg -25%
range: -15% to -35%· sector pattern — no exact same-company precedent yet
No exact same-company precedent for a bad assay result exists yet; sized using the stock's own demonstrated volatility pattern and general small-cap mining sector reactions to disappointing drill results.
💼Spot Position Sizing
How the recommended % is derived
3%
of portfolio

ค่าขนม sizing — genuine scale resource asset with real offtake validation, but active recurring dilution and pre-revenue execution risk argue for small, speculative-tier sizing only.

🛑Stop Loss · Spot Trade
Spot cut-loss levels — separate from the core holding
Before Catalyst
-25%($5.5)
Below Entry 2 zone before assay results = fresh dilution or sentiment concerns building
After Catalyst (Bad Result)-35%
If assay results disappoint or another large dilutive shelf offering is announced, exit
📎 Sources

Generated 2026-07-14 · Not financial advice